Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Zonisamide as a New Treatment for Post-Traumatic Stress Disorder and Co-Occurring Alcohol Use Disorder

NCT03376139 is registered in ClinicalTrials.gov with Pharmacotherapies for Alcohol and Substance Use Disorders Alliance as lead sponsor.

NCT NCT03376139
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03376139 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Zonisamide as a New Treatment for Post-Traumatic Stress Disorder and Co-Occurring Alcohol Use Disorder
Lead sponsor
Pharmacotherapies for Alcohol and Substance Use Disorders Alliance
Phase
Phase 2
Overall status
Withdrawn
Start date
March 1, 2019
Completion date
August 31, 2019
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder, post traumatic stress disorder